Ipca Labs Q3 results: Profit up 67% at Rs 180 crore
The drugmaker had reported a net profit of Rs 108 crore for October-December FY23. Revenue from operations rose to Rs 2,053 crore from Rs 1,546 crore in the year-ago period, Ipca Laboratories said in a regulatory filing
The drugmaker had reported a net profit of Rs 108 crore for October-December FY23. Image Courtesy: Ipca Laboratories